Want to see OABI full AI Analyst Report?

OmniAb (OABI) Stock Forecast & Price Target

314 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

OABI Analyst Ratings

Strong Buy

5 Buy

0 Hold

0 Sell

Based on 5 analysts giving stock ratings to

OmniAb

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

OABI Stock 12 Month Forecast

Average Price Target

$8.00

▲(306.09% Upside)

Based on 5 Wall Street analysts offering 12 month price targets for OmniAb in the last 3 months. The average price target is $8.00 with a high forecast of $11.00 and a low forecast of $5.00. The average price target represents a 306.09% change from the last price of $1.97.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","3":"$3","6":"$6","9":"$9","12":"$12"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":11,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$11.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":8,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$8.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$5.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,3,6,9,12],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.98,2.6738461538461538,3.3676923076923075,4.061538461538461,4.7553846153846155,5.449230769230769,6.143076923076922,6.836923076923076,7.530769230769231,8.224615384615385,8.918461538461537,9.612307692307692,10.306153846153846,{"y":11,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.98,2.443076923076923,2.9061538461538463,3.3692307692307693,3.832307692307692,4.295384615384615,4.758461538461539,5.2215384615384615,5.684615384615384,6.147692307692308,6.610769230769231,7.073846153846153,7.5369230769230775,{"y":8,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.98,2.212307692307692,2.4446153846153846,2.6769230769230767,2.9092307692307693,3.1415384615384614,3.373846153846154,3.606153846153846,3.838461538461538,4.070769230769231,4.303076923076922,4.535384615384615,4.7676923076923075,{"y":5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1.91,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.58,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.61,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.55,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.74,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.85,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.79,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.76,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.56,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.4,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.61,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.39,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.98,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$11.00

Average Price Target$8.00

Lowest Price Target$5.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Srikripa Devarakonda

Truist Financial

―

Buy

―

Reiterated

08/18/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Argenx Se (NASDAQ: ARGX), Fulcrum Therapeutics (NASDAQ: FULC) and OmniAb (NASDAQ: OABI)

Joseph Pantginis

H.C. Wainwright

$11

Buy

458.38%

Upside

Reiterated

08/17/26

H.C. Wainwright Keeps Their Buy Rating on OmniAb (OABI)

Brendan Smith

TD Cowen

$3→$5

Buy

153.81%

Upside

Reiterated

08/17/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: OmniAb (NASDAQ: OABI), Bicycle Therapeutics (NASDAQ: BCYC) and 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP)

Matt Hewitt

Craig-Hallum

Buy

255.33%

Upside

Reiterated

08/17/26

Analysts Offer Insights on Healthcare Companies: OmniAb (NASDAQ: OABI), Neurocrine (NASDAQ: NBIX) and Evaxion Biotech (NASDAQ: EVAX)

Stephen Willey

Stifel Nicolaus

Buy

356.85%

Upside

Reiterated

08/07/26

Stifel Nicolaus Sticks to Its Buy Rating for OmniAb (OABI)

Robert Wasserman

Benchmark Co.

$6→$4

Buy

103.05%

Upside

Reiterated

11/06/25

Benchmark Co. Remains a Buy on OmniAb (OABI)

Conor McNamara

RBC Capital

Buy

52.28%

Upside

Reiterated

09/02/25

OmniAb (OABI) Receives a Buy from RBC Capital

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Srikripa Devarakonda

Truist Financial

―

Buy

―

Reiterated

08/18/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Argenx Se (NASDAQ: ARGX), Fulcrum Therapeutics (NASDAQ: FULC) and OmniAb (NASDAQ: OABI)

Joseph Pantginis

H.C. Wainwright

$11

Buy

458.38%

Upside

Reiterated

08/17/26

H.C. Wainwright Keeps Their Buy Rating on OmniAb (OABI)

Brendan Smith

TD Cowen

$3→$5

Buy

153.81%

Upside

Reiterated

08/17/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: OmniAb (NASDAQ: OABI), Bicycle Therapeutics (NASDAQ: BCYC) and 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP)

Matt Hewitt

Craig-Hallum

Buy

255.33%

Upside

Reiterated

08/17/26

Analysts Offer Insights on Healthcare Companies: OmniAb (NASDAQ: OABI), Neurocrine (NASDAQ: NBIX) and Evaxion Biotech (NASDAQ: EVAX)

Stephen Willey

Stifel Nicolaus

Buy

356.85%

Upside

Reiterated

08/07/26

Stifel Nicolaus Sticks to Its Buy Rating for OmniAb (OABI)

Robert Wasserman

Benchmark Co.

$6→$4

Buy

103.05%

Upside

Reiterated

11/06/25

Benchmark Co. Remains a Buy on OmniAb (OABI)

Conor McNamara

RBC Capital

Buy

52.28%

Upside

Reiterated

09/02/25

OmniAb (OABI) Receives a Buy from RBC Capital

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

AVBPArriVent BioPharma, Inc.

BTSGBrightSpring Health Services, Inc.

AMLXAmylyx Pharmaceuticals Inc

IMMXImmix Biopharma

JBIOJade Biosciences

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering OmniAb

3 Months

Matt HewittCraig-Hallum

Success Rate

12/21 ratings generated profit

Average Return

+15.26%

Copying Matt Hewitt's trades and holding each position for 3 Months would result in 57.14% of your transactions generating a profit, with an average return of +15.26% per trade.

1 Year

Matt HewittCraig-Hallum

Success Rate

10/21 ratings generated profit

Average Return

+37.34%

Copying Matt Hewitt's trades and holding each position for 1 Year would result in 47.62% of your transactions generating a profit, with an average return of +37.34% per trade.

2 Years

Conor McNamaraRBC Capital

Success Rate

10/17 ratings generated profit

Average Return

+40.05%

Copying Conor McNamara's trades and holding each position for 2 Years would result in 58.82% of your transactions generating a profit, with an average return of +40.05% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

OABI Analyst Recommendation Trends

Rating

Apr 26

May 26

Jun 26

Jul 26

Aug 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, OABI has received 10 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. OABI average Analyst price target in the past 3 months is 8.00.

Each month's total comprises the sum of three months' worth of ratings.

OABI Financial Forecast

OABI Earnings Forecast

Next quarter’s earnings estimate for OABI is -$0.13 with a range of -$0.14 to -$0.11. The previous quarter’s EPS was -$0.05. OABI beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year OABI has Performed in-line its overall industry.

OABI Sales Forecast

Next quarter’s sales forecast for OABI is $3.43M with a range of $2.93M to $3.90M. The previous quarter’s sales results were $13.41M. OABI beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year OABI has Performed in-line its overall industry.

OABI Stock Forecast FAQ

What is OABI’s average 12-month price target, according to analysts?

Based on analyst ratings, OmniAb’s 12-month average price target is 8.00.

What is OABI’s upside potential, based on the analysts’ average price target?

OmniAb has 306.09% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is OABI a Buy, Sell or Hold?

OmniAb has a consensus rating of Strong Buy which is based on 5 buy ratings, 0 hold ratings and 0 sell ratings.

What is OmniAb’s price target?

The average price target for OmniAb is 8.00. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $11.00 ,the lowest forecast is $5.00. The average price target represents 306.09% Increase from the current price of $1.97.

What do analysts say about OmniAb?

OmniAb’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.

How can I buy shares of OABI?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

OmniAb (OABI) Stock Forecast & Price Target

OABI Analyst Ratings

OABI Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering OmniAb

OABI Analyst Recommendation Trends

OABI Financial Forecast

OABI Earnings Forecast

OABI Sales Forecast

OABI Stock Forecast FAQ

Detailed List of Analyst Forecasts